Jan Drappatz

5PUBLICATIONS
65CO-AUTHORS
Haematological tumoursMolecular targetsTumour immunologyImmunogenetics (incl. genetic immunology)Clinical neuropsychology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 11, 2025
Treatment strategies and innovation for recurrent high-grade glioma.

Jan Drappatz, Megan Mantica

|Jun 05, 2024
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT.

Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz

|Jul 10, 2023
Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma.

Michal Nisnboym, Sarah R Vincze, Zujian Xiong

|Mar 27, 2023
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent <i>IDH1-</i> and <i>IDH2</i>-mutant Glioma.

Kristina Fanucci, Mary Jo Pilat, Derek Shyr

|Sep 13, 2019
Psychometric Evaluation of the Caregiver Needs Screen in Neuro-Oncology Family Caregivers.

Florien W Boele, Lauren Terhorst, Jennifer Prince

Pageof 1